Archer S - Search Results

1

Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry.

Gallagher CA, Hough LB, Keefner SM, Seyed-Mozaffari A, Archer S, Glick SD. Gallagher CA, et al. Among authors: archer s. Biochem Pharmacol. 1995 Jan 6;49(1):73-9. doi: 10.1016/0006-2952(94)00441-n. Biochem Pharmacol. 1995. PMID: 7840786

2

Antinociceptive evaluation of 14 beta-(bromoacetamido)-7,8-dihydro- N(cyclopropylmethyl)-normorphinone in mice.

Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM. Jiang Q, et al. Among authors: archer s. Eur J Pharmacol. 1993 Aug 24;240(2-3):201-6. doi: 10.1016/0014-2999(93)90899-s. Eur J Pharmacol. 1993. PMID: 7694857 Free article.

3

Synthesis and characterization of 7-nitrobenzo-2-oxa-1,3-diazole (NBD)-labeled fluorescent opioids.

Archer S, Medzihradsky F, Seyed-Mozaffari A, Emmerson PJ. Archer S, et al. Biochem Pharmacol. 1992 Jan 22;43(2):301-6. doi: 10.1016/0006-2952(92)90292-q. Biochem Pharmacol. 1992. PMID: 1371213 Free article.

4

U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats.

Maisonneuve IM, Archer S, Glick SD. Maisonneuve IM, et al. Among authors: archer s. Neurosci Lett. 1994 Nov 7;181(1-2):57-60. doi: 10.1016/0304-3940(94)90559-2. Neurosci Lett. 1994. PMID: 7898771

5

Kappa opioid inhibition of morphine and cocaine self-administration in rats.

Glick SD, Maisonneuve IM, Raucci J, Archer S. Glick SD, et al. Among authors: archer s. Brain Res. 1995 May 29;681(1-2):147-52. doi: 10.1016/0006-8993(95)00306-b. Brain Res. 1995. PMID: 7552272

6

N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.

Xu JY, Seyed-Mozaffari A, Archer S, Bidlack JM. Xu JY, et al. Among authors: archer s. J Pharmacol Exp Ther. 1996 Nov;279(2):539-47. J Pharmacol Exp Ther. 1996. PMID: 8930155

7

Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO).

Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM. Jiang Q, et al. Among authors: archer s. J Pharmacol Exp Ther. 1992 Aug;262(2):526-31. J Pharmacol Exp Ther. 1992. PMID: 1380079

8

Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).

Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM. Jiang Q, et al. Among authors: archer s. J Pharmacol Exp Ther. 1993 Mar;264(3):1021-7. J Pharmacol Exp Ther. 1993. PMID: 7680715

9

Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism.

Jiang Q, Seyed-Mozaffari A, Sebastian A, Archer S, Bidlack JM. Jiang Q, et al. Among authors: archer s. J Pharmacol Exp Ther. 1995 May;273(2):680-8. J Pharmacol Exp Ther. 1995. PMID: 7752070

10

Photoaffinity ligands for the mu opioid receptor.

Simon EJ, Fan LQ, Hiller JM, Seyed-Mozaffari A, Schultz AG, Archer S. Simon EJ, et al. Among authors: archer s. Life Sci. 1993;53(14):1173-8. doi: 10.1016/0024-3205(93)90554-g. Life Sci. 1993. PMID: 8396706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,208 results

Search Page

Filters